Should You Buy Quidel Corporation (QDEL) Stock After it Has Fallen 10.27% in a Week?

The market has been down on Quidel Corporation (QDEL) stock recently. QDEL gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Quidel Corporation has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on QDEL!

See Full QDEL Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With QDEL Stock Today?

Quidel Corporation (QDEL) stock is up 3.44% while the S&P 500 is down -0.78% as of 1:26 PM on Thursday, May 12. QDEL is up $3.06 from the previous closing price of $89.06 on volume of 262,153 shares. Over the past year the S&P 500 is down -5.96% while QDEL is down -19.70%. QDEL earned $23.45 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.93. To see InvestorsObserver's Sentiment Score for Quidel Corporation click here.

More About Quidel Corporation

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays. Click Here to get the full Stock Report for Quidel Corporation stock.